 |
Published by the Johns Hopkins Center for Health Security
Editors: Diane Meyer, RN, MPH; Divya Hosangadi, MSPH & Amanda Kobokovich, MPH
|
Participate in the Center for Health Security's Infectious Disease Prediction Project.
Researchers at the Johns Hopkins Center for Health Security are challenging the crowd to make predictions about future outbreaks and other related events for a project that will provide public health leaders with forecasting data to help inform their decisions on preparedness and response policies and interventions. Participation is open to public health experts, doctors, epidemiologists, modelers, risk experts, vector control officials, individuals with on-the-ground understanding of conditions surrounding disease outbreaks, and others who are interested in outbreaks. Participants who make accurate predictions and update their forecasts consistently may become eligible for a prize. More information and a registration link are available here.
|
|
|
Public Health & Healthcare Preparedness
|
|
NEWS
Investigational Monoclonal Antibody to Treat Ebola Is Safe in Adults. The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet. Eighteen healthy adults received the monoclonal antibody as part of a Phase 1 clinical trial that began in May 2018 at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.
(NIH, 2/24/19)
|
|
RESEARCH
Lassa Fever in Travelers from West Africa, 1969-2016. Lassa virus is a rodentborne arenavirus responsible for human cases of Lassa fever, a viral hemorrhagic fever, in West Africa and in travelers arriving to non-Lassa-endemic countries from West Africa. This article describes a retrospective review performed through literature search of clinical and epidemiologic characteristics of all imported Lassa fever cases worldwide during 1969-2016.
(CDC, 2/19)
|
|
RESEARCH
Ebola Virus Infection Associated with Transmission from Survivors. Ebola virus (EBOV) can persist in immunologically protected body sites in survivors of Ebola virus disease, creating the potential to initiate new chains of transmission. From the outbreak in West Africa during 2014-2016, the authors identified 13 possible events of viral persistence-derived transmission of EBOV (VPDTe) and applied predefined criteria to classify transmission events based on the strength of evidence for VPDTe and source and route of transmission.
(CDC, 2/19)
|
|
ANNOUNCEMENT
Applications for the 2019 National Health Security Award Now Open. The National Association of County and City Health Officials and the US Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response are pleased to announce the fourth annual National Health Security Award! This award recognizes local health departments that have demonstrated significant accomplishments in implementing health security-related initiatives within their jurisdictions.
(NACCHO, 1/19)
|
|
Homeland Security & Disaster Preparedness
|
|
WORKSHOP
Disaster Research Response (DR2) Tucson Workshop. Jointly sponsored by National Institute of Environmental Health Sciences (NIEHS) and University of Arizona College of Medicine- Tucson, the Mel and Enid Zuckerman College of Public Health, the University of Arizona College of Pharmacy and the Bio5 Institute, the workshop will center around facilitated discussions using a realistic scenario.
(NIH, 2/19)
|
|
SYMPOSIUM
2019 Joint Civil & DoD CBRN Symposium. The 2019 Joint Civil & DoD CBRN Symposium will provide a forum for members of the DoD, Federal Government, State and Local Government, Private Industry, Academia, and other relevant CBRN stakeholders to discuss the latest updates in advancing a government wide approach to improving CBRN defense, readiness and response strategies and capabilities.
(Defense Strategies Institute, 2/19)
|
|
Radiological & Nuclear Disaster Preparedness
|
|
Science & Technology Policy
|
|
|
|
|
|
